SENS
Senseonics Holdings, Inc. [SENS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SENS Stock Summary
Top 10 Correlated ETFs
SENS
Top 10 Correlated Stocks
SENS
In the News
SENS Financial details
Company Rating
Neutral
Market Cap
255.25M
Income
-44.01M
Revenue
22.39M
Book val./share
0.14
Cash/share
0.21
Dividend
-
Dividend %
-
Employees
132
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-11.38
Forward P/E
-
PEG
0.91
P/S
14.85
P/B
6.37
P/C
1.91
P/FCF
-4.07
Quick Ratio
7.45
Current Ratio
8.45
Debt / Equity
0.57
LT Debt / Equity
0.56
-
-
EPS (TTM)
-0.07
EPS next Y
-
EPS next Q
-
EPS this Y
-136.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-30.33%
Revenue last 5Y
1%
Revenue Q/Q
31.7%
EPS Q/Q
-20.39%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
10.35%
Inst Trans
0.65%
ROA
-19%
ROE
-70%
ROC
-0.57%
Gross Margin
13%
Oper. Margin
-389%
Profit Margin
-146%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.461-1.05
52W High
-
52W Low
-
RSI
29
Rel Volume
0.72
Avg Volume
2.49M
Volume
1.79M
Perf Week
-19.8%
Perf Month
-35.72%
Perf Quarter
-16.64%
Perf Half Y
-23.22%
-
-
-
-
Beta
0.894
-
-
Volatility
0.03%, 0.06%
Prev Close
-3.41%
Price
0.4018
Change
-2%
SENS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.11 | 0.02 | 0.03 | 0.04 | 0.04 | |
| Net income per share | -0.67 | -0.84 | -0.75 | 0.3 | -0.11 | |
| Operating cash flow per share | -0.72 | -0.3 | -0.13 | -0.14 | -0.12 | |
| Free cash flow per share | -0.73 | -0.3 | -0.13 | -0.14 | -0.12 | |
| Cash per share | 0.51 | 0.08 | 0.31 | 0.31 | 0.19 | |
| Book value per share | -0.05 | -0.63 | -0.44 | -0.01 | 0.13 | |
| Tangible book value per share | -0.05 | -0.63 | -0.44 | -0.01 | 0.13 | |
| Share holders equity per share | -0.05 | -0.63 | -0.44 | -0.01 | 0.13 | |
| Interest debt per share | 0.7 | 0.35 | 0.19 | 0.2 | 0.09 | |
| Market cap | 172.9M | 198.69M | 1.13B | 481.99M | 323.8M | |
| Enterprise value | 196.19M | 243.38M | 1.16B | 520.85M | 295.87M | |
| P/E ratio | -1.37 | -1.04 | -3.55 | 3.39 | -5.36 | |
| Price to sales ratio | 8.12 | 40.15 | 82.46 | 29.41 | 14.46 | |
| POCF ratio | -1.27 | -2.95 | -20.11 | -7.27 | -4.62 | |
| PFCF ratio | -1.26 | -2.94 | -20.03 | -7.23 | -4.59 | |
| P/B Ratio | -19.53 | -1.38 | -6.08 | -187.11 | 4.41 | |
| PTB ratio | -19.53 | -1.38 | -6.08 | -187.11 | 4.41 | |
| EV to sales | 9.21 | 49.18 | 84.64 | 31.78 | 13.21 | |
| Enterprise value over EBITDA | -1.48 | -2.64 | -20.27 | -7.78 | -3.98 | |
| EV to operating cash flow | -1.44 | -3.61 | -20.64 | -7.85 | -4.22 | |
| EV to free cash flow | -1.43 | -3.6 | -20.56 | -7.82 | -4.2 | |
| Earnings yield | -0.73 | -0.96 | -0.28 | 0.29 | -0.19 | |
| Free cash flow yield | -0.79 | -0.34 | -0.05 | -0.14 | -0.22 | |
| Debt to equity | -13.47 | -0.44 | -0.34 | -28.98 | 0.57 | |
| Debt to assets | 0.9 | 1.75 | 0.32 | 0.42 | 0.3 | |
| Net debt to EBITDA | -0.18 | -0.49 | -0.52 | -0.58 | 0.38 | |
| Current ratio | 1.01 | 1.82 | 7.85 | 5.12 | 7.53 | |
| Interest coverage | -10.71 | -4.89 | -3.42 | -3.67 | -6.8 | |
| Income quality | 1.18 | 0.38 | 0.19 | -0.47 | 1.16 | |
| Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
| Payout ratio | 0 | 0 | -0.02 | 0.02 | 0 | |
| Sales general and administrative to revenue | 1.09 | 4.2 | 1.57 | 0 | 0 | |
| Research and developement to revenue | 1.8 | 4.12 | 1.99 | 2.42 | 2.18 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.01 | 0 | 0 | 0 | 0 | |
| Capex to revenue | -0.05 | -0.04 | -0.02 | -0.02 | -0.02 | |
| Capex to depreciation | -1.04 | -0.16 | -0.17 | -0.32 | -0.27 | |
| Stock based compensation to revenue | 0.38 | 1.48 | 0.66 | 0.53 | 0.39 | |
| Graham number | 0.84 | 3.45 | 2.73 | 0.19 | 0.56 | |
| ROIC | -1.26 | 1.09 | 0.49 | -0.8 | -0.62 | |
| Return on tangible assets | -0.95 | -5.32 | -1.6 | 0.8 | -0.44 | |
| Graham Net | -0.15 | -0.69 | -0.59 | -0.07 | 0.09 | |
| Working capital | 1.05M | 13.61M | 126.02M | 129.73M | 112.77M | |
| Tangible asset value | -8.85M | -144.08M | -185.54M | -2.58M | 73.45M | |
| Net current asset value | -13.69M | -149.76M | -240.05M | -19.05M | 65.26M | |
| Invested capital | -13.47 | -0.44 | -0.34 | -28.98 | 0.57 | |
| Average receivables | 8.79M | 6.74M | 2.48M | 2.21M | 3.63M | |
| Average payables | 4.35M | 3.02M | 1.48M | 811.5K | 2.49M | |
| Average inventory | 13.58M | 11.11M | 5.8M | 6.81M | 8.04M | |
| Days sales outstanding | 179.68 | 220.22 | 52.66 | 54.59 | 78.31 | |
| Days payables outstanding | 38.38 | 28.82 | 30.34 | 11.19 | 86.39 | |
| Days of inventory on hand | 151.64 | 86.38 | 159.14 | 195.18 | 165.98 | |
| Receivables turnover | 2.03 | 1.66 | 6.93 | 6.69 | 4.66 | |
| Payables turnover | 9.51 | 12.66 | 12.03 | 32.61 | 4.22 | |
| Inventory turnover | 2.41 | 4.23 | 2.29 | 1.87 | 2.2 | |
| ROE | 14.26 | 1.33 | 1.71 | -55.17 | -0.82 | |
| Capex per share | -0.01 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Net income per share | 0 | 0.04 | -0.04 | -0.04 | -0.03 | |
| Operating cash flow per share | -0.04 | -0.04 | -0.03 | -0.03 | -0.03 | |
| Free cash flow per share | -0.04 | -0.04 | -0.03 | -0.03 | -0.03 | |
| Cash per share | 0.3 | 0.26 | 0.21 | 0.21 | 0.21 | |
| Book value per share | -0.01 | 0.13 | 0.09 | 0.09 | 0.14 | |
| Tangible book value per share | -0.01 | 0.13 | 0.09 | 0.09 | 0.14 | |
| Share holders equity per share | -0.01 | 0.13 | 0.09 | 0.09 | 0.14 | |
| Interest debt per share | 0.16 | 0.09 | 0.09 | 0.08 | 0.08 | |
| Market cap | 494.03M | 353.21M | 432.77M | 357.78M | 302.36M | |
| Enterprise value | 530.2M | 348.18M | 450.22M | 348.82M | 274.43M | |
| P/E ratio | -52.76 | 4.99 | -5.3 | -3.71 | -4.4 | |
| Price to sales ratio | 88.68 | 85.38 | 104.89 | 58.68 | 37.65 | |
| POCF ratio | -28.41 | -17.8 | -24.06 | -20.72 | -20.4 | |
| PFCF ratio | -28.32 | -17.74 | -24.06 | -20.58 | -20.17 | |
| P/B Ratio | -191.78 | 5.48 | 8.24 | 6.87 | 4.12 | |
| PTB ratio | -191.78 | 5.48 | 8.24 | 6.87 | 4.12 | |
| EV to sales | 95.17 | 84.16 | 109.12 | 57.21 | 34.18 | |
| Enterprise value over EBITDA | -29.61 | -18.74 | -24.76 | -19.88 | -16.77 | |
| EV to operating cash flow | -30.49 | -17.54 | -25.03 | -20.21 | -18.51 | |
| EV to free cash flow | -30.39 | -17.49 | -25.03 | -20.06 | -18.3 | |
| Earnings yield | 0 | 0.05 | -0.05 | -0.07 | -0.06 | |
| Free cash flow yield | -0.04 | -0.06 | -0.04 | -0.05 | -0.05 | |
| Debt to equity | -27.94 | 0.63 | 0.88 | 0.91 | 0.57 | |
| Debt to assets | 0.41 | 0.26 | 0.3 | 0.31 | 0.3 | |
| Net debt to EBITDA | -2.02 | 0.27 | -0.96 | 0.51 | 1.71 | |
| Current ratio | 5.12 | 10.25 | 8.72 | 8.45 | 7.53 | |
| Interest coverage | -3.85 | -4.24 | -8.6 | -7.84 | -9.87 | |
| Income quality | -1.5 | -14.99 | 0.88 | 0.72 | 0.86 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | -0.71 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 1.14 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 2.09 | 3 | 3.11 | 2.09 | 1.34 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0.01 | 0.01 | |
| Capex to revenue | -0.01 | -0.01 | 0 | -0.02 | -0.02 | |
| Capex to depreciation | -0.24 | -0.24 | 0 | -0.66 | -0.27 | |
| Stock based compensation to revenue | 0.37 | 0.43 | 0.7 | 0.34 | 0.24 | |
| Graham number | 0.02 | 0.32 | 0.27 | 0.28 | 0.32 | |
| ROIC | 0.05 | -2.45 | -0.21 | -0.2 | -0.14 | |
| Return on tangible assets | -0.01 | 0.11 | -0.13 | -0.16 | -0.12 | |
| Graham Net | -0.06 | 0.08 | 0.05 | 0.05 | 0.1 | |
| Working capital | 129.73M | 132.06M | 122.37M | 128.84M | 112.77M | |
| Tangible asset value | -2.58M | 64.46M | 52.54M | 52.07M | 73.45M | |
| Net current asset value | -19.05M | 52.27M | 37.4M | 44.14M | 65.26M | |
| Invested capital | -27.94 | 0.63 | 0.88 | 0.91 | 0.57 | |
| Average receivables | 2.47M | 2.93M | 4.56M | 4.58M | 4.13M | |
| Average payables | 551.5K | 532.5K | 810.5K | 1.82M | 3.62M | |
| Average inventory | 7.28M | 7.75M | 8.69M | 9.46M | 9.25M | |
| Days sales outstanding | 39.6 | 74.05 | 124.53 | 50.93 | 53.84 | |
| Days payables outstanding | 7.62 | 15.62 | 23.66 | 48.77 | 59.23 | |
| Days of inventory on hand | 132.78 | 198.11 | 223.1 | 177.73 | 113.79 | |
| Receivables turnover | 2.27 | 1.22 | 0.72 | 1.77 | 1.67 | |
| Payables turnover | 11.82 | 5.76 | 3.8 | 1.85 | 1.52 | |
| Inventory turnover | 0.68 | 0.45 | 0.4 | 0.51 | 0.79 | |
| ROE | 0.91 | 0.27 | -0.39 | -0.46 | -0.23 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
SENS Frequently Asked Questions
What is Senseonics Holdings, Inc. stock symbol ?
Senseonics Holdings, Inc. is a US stock , located in Germantown of Md and trading under the symbol SENS
What is Senseonics Holdings, Inc. stock quote today ?
Senseonics Holdings, Inc. stock price is $0.4018 today.
Is Senseonics Holdings, Inc. stock public?
Yes, Senseonics Holdings, Inc. is a publicly traded company.
Company Profile
- Volume Average 2.49M
- Market Capitalization 255.25M
- Employee 132
- CEO Dr. Timothy T. Goodnow Ph.D.
- Headquarters Germantown,MD,US
- IPO Date 2015-12-22
-
Website
https://www.senseonics.com 
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
